Allogeneic mRNA-based electrotransfection of autologous dendritic cells and specific antitumor effects against osteosarcoma in rats

Medical Oncology

Volumn 29, Issue 5, 2012, Pages 3440-3448

  Yu, Zhe ^a   Qian, Jixian ^a   Wu, Jiachang ^a   Gao, Jie ^a   Zhang, Minghua ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Allogeneic; Autologous; Cytotoxic T lymphocytes; Dendritic cell; Immunotherapy; mRNA; Osteosarcoma

Indexed keywords

HLA ANTIGEN CLASS 1; MESSENGER RNA; TUMOR ANTIGEN; TUMOR VACCINE; CANCER VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; ELECTROPORATION; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IN VIVO STUDY; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; RAT; RNA PURIFICATION; WISTAR RAT; ALLOTRANSPLANTATION; ANIMAL; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; MALE; METHODOLOGY; SPRAGUE DAWLEY RAT; TRANSPLANTATION;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; ELECTROPORATION; IMMUNOTHERAPY; MALE; OSTEOSARCOMA; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RNA, MESSENGER; TRANSFECTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84880256591     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-012-0312-y     Document Type: Article

References (28)

1. Mosca PJ, Lyerly HK, Clay TM, et al. Dendritic cell vaccines. Front Biosci. 2007;12:4050-60.
2. Kim CH, Hong MJ, Park SD, et al. Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12. Cancer Immunol Immunother. 2006;55:1309-19.
3. Yokomine K, Nakatsura T, Minohara M, et al. Immunization with heat shock protein 105-pulsed dendritic cells leads to tumor rejection in mice. Biochem Biophys Res Commun. 2006;343:269-78.
4. Yu Z, Ma B, Zhou Y, et al. Activation of antitumor cytotoxic T lymphocytes by fusion of patient-derived dendritic cells with autologous osteosarcoma. Exp Oncol. 2005;27:273-8.
5. Gong J, Nikrui N, Chen D, et al. Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity. J Immunol. 2000;165:1705-11.
6. Siders WM, Vergilis KL, Johnson C, et al. Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells. Mol Ther. 2003;7:498-505.
7. Ribas A. Clinical trials with tumor antigen genetically modified dendritic cells. Semin Oncol. 2005;32:556-62.
8. Müller MR, Grünebach F, Nencioni A, et al. Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes. J Immunol. 2003;170:5892-6.
9. Jarnjak-Jankovic S, Saebøe-Larssen S, Kvalheim G, et al. mRNA transfection of DC in the immature or mature state: comparable in vitro priming of Th and cytotoxic T lymphocytes against DC electroporated with tumor cell line-derived mRNA. Cytotherapy. 2007;9:587-92.
10. Hu Y, He Y, Srivenugopal KS, et al. In vitro antitumor cytotoxic T lymphocyte response induced by dendritic cells transduced with DeltaNp73alpha recombinant adenovirus. Oncol Rep. 2007;18:1085-91.
11. Kyte JA, Gaudernack G. Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells. Cancer Immunol Immunother. 2006;55:1432-42.
12. Amano T, Kajiwara K, Yoshikawa K, et al. Antitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan-mediated motility mRNA in a mouse glioma model. J Neurosurg. 2007;106:638-45.
13. Fan QY, Ma BA, Zhou Y, et al. Bone tumors of the extremities or pelvis treated by microwave-induced hyperthermia. Clin Orthop. 2003;406:165-75.
14. Varan A, Yazici N, Aksoy C, et al. Treatment results of pediatric osteosarcoma: twenty-year experience. J Pediatr Orthop. 2007;27:241-6.
15. Ferrari S, Palmerini E. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr Opin Oncol. 2007;19:341-6.
16. Mu LJ, Gaudernack G, Sæbøe-Larssen S, et al. A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines. Gene Ther. 2003;10:367-74.
17. Sæbøe-Larssen S, Fossberg E, et al. mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT). J Immunol Methods. 2002;259:191-203.
18. Yu Z, Sun H, Fan Q, et al. Establishment of reproducible osteosarcoma rat model using orthotopic implantation technique. Oncol Rep. 2009;21:1175-80.
19. Yu Z, Ma B, Zhou Y, et al. Allogeneic tumor vaccine produced by electrofusion between osteosarcoma cell line and dendritic cells in the induction of antitumor immunity. Cancer Invest. 2007;25:535-41.
20. Kreiter S, Diken M, Selmi A, et al. Tumor vaccination using messenger RNA: prospects of a future therapy. Curr Opin Immunol. 2011;23:399-406.
21. Mu LJ, Kyte JA, Kvalheim G, et al. Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients. Br J Cancer. 2005;93:749-56.
22. Yu Z, Sun H, Zhang T, et al. Specific antitumor effects of tumor vaccine produced by autologous dendritic cells transfected with allogeneic osteosarcoma total RNA through electroporation in rats. Cancer Biol Ther. 2009;8:973-80.
23. Gholamin M, Moaven O, Farshchian M, et al. Induction of cytotoxic T lymphocytes primed with tumor RNA-loaded dendritic cells in esophageal squamous cell carcinoma: preliminary step for DC vaccine design. BMC Cancer. 2010;10:261.
24. Melhem NM, Gleason SM, Liu XD, et al. High-level antigen expression and sustained antigen presentation in dendritic cells nucleofected with wild-type viral mRNA but not DNA. Clin Vaccine Immunol. 2008;15:1337-44.
25. Ni X, Richmond HM, Liao XM, et al. Induction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA. J Invest Dermatol. 2008;128:2631-9.
26. Wilgenhof S, Van Nuffel AM, Corthals J, et al. Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma. J Immunother. 2011;34:448-56.
27. Lesterhuis WJ, De Vries IJ, Schreibelt G, et al. Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients. Anticancer Res. 2010;30:5091-7.
28. Zhang Y, Ma B, Zhou Y, et al. Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells. Breast Cancer Res Treat. 2007;105(3):277-86.